[Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].

@article{Cosset2013PermanentIP,
  title={[Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].},
  author={J M Cosset and Jean-Michel Hannoun-L{\'e}vi and Didier Peiffert and Martine Delannes and Pascal Pommier and Noelle Pierrat and Philippe Nickers and Laurence Thomas and Laurent Chauveinc},
  journal={Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique},
  year={2013},
  volume={17 2},
  pages={111-7}
}
With an experience of more than 25 years for the pioneers (and more than 14 years in France), permanent implant brachytherapy using iodine 125 seeds (essentially) is now recognized as a valuable alternative therapy for localized low-risk prostate cancer patients. The possible extension of the indications of exclusive brachytherapy towards selected patients in the intermediate-risk group has now been confirmed by several studies. Moreover, for the other patients in the intermediate-risk group… CONTINUE READING
1 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…